CMMB NASDAQ
Chemomab Therapeutics Ltd.
1W: -33.8%
1M: -47.6%
3M: -40.4%
YTD: -20.1%
1Y: -45.8%
3Y: -60.7%
5Y: -97.0%
$1.43
+0.13 (+10.00%)
Weekly Expected Move ±20.2%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-8M
Net Income
+35.7% YoY
$-21M
Free Cash Flow
-18.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-82.7%
ROA-71.2%
ROIC-314.7%
Valuation
P/E-1.4
P/B1.3
EV/EBITDA-0.8
Leverage
Debt/Equity0.00
Current Ratio6.41
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-12.37
Beneish M0.00